title: [Ventricular fibrillation in a patient with myelodysplastic syndrome treated with small doses of cytarabine].
abstract: The paper presented a case of a patient with type III by FAB myelodysplastic syndrome, in whom during a low dose cytarabine therapy ventricular fibrillation occurred. Authors discussed roles of anemia, ischemic heart disease and hypokalemia as factors which could increase circulatory system sensitivity on cytarabine action.
authors.forename: J
authors.initials: J
authors.lastname: Drzewoski
authors.forename: E
authors.initials: E
authors.lastname: Krykowski
authors.forename: T
authors.initials: T
authors.lastname: Robak
authors.forename: P
authors.initials: P
authors.lastname: Jerzmanowski
authors.forename: J
authors.initials: J
authors.lastname: Kusowska
authors.forename: H
authors.initials: H
authors.lastname: Koźbiał
mesh_terms: D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D014693:Ventricular Fibrillation / Q000139:chemically induced*
chemical_list: D003561:Cytarabine
vernacular_title: Migotanie komór u chorego z zespołem mielodysplastycznym leczonego małymi dawkami cytarabiny.